Home /
Novo Nordisk and Eli Lilly bet on obesity treatment pills Novo Nordisk and Eli Lilly introduce oral versions of their weight-loss drugs.
Published 6sem · 1 source Important
The fact These pills, already available in the U.S., aim to expand access to their injectable treatments.
International rollout is planned following a successful launch.
🔗 Click the link to read an article on the topic:
Why it matters Ces médicaments pourraient transformer le marché des traitements contre l'obésité, avec un impact sur les systèmes de santé et les coûts pour les patients dès leur commercialisation en Europe et ailleurs.
What if you saw the whole news differently? Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page. → États-Unis · © OpenStreetMap, OpenMapTiles, OpenFreeMap World map → Auto-synthesis from 1 media source · identified on August 7, 2026